Message #8 From:
Stock News Bot Date: July 25, 2005 02:00:00 AM
GTHA News GeneThera Announces Strategic Alliance Partnership with Nutricion Avanzada
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--July 25, 2005--In line with its strategic direction to commercialize a live animal test for several veterinary diseases, GeneThera (OTCBB:GTHA) announces its strategic alliance partnership with Nutricion Avanzada of Monterrey, Mexico.
Nutricion Avanzada is a large private multinational distributor of nutritional supplements for animals with access to large amounts of cattle throughout Mexico.
The agreement between the companies allows access for Nutricion Avanzada to GeneThera's proprietary diagnostic solution based on its genetic expression assay, GEA(TM).
GeneThera will gain access to Nutricion Avanzada's customer base as well as gain a physical presence in Mexico at Nutricion Avanzada's Monterrey facilities.
Commenting on the partnership between the companies, Dr. Tony Milici, CEO of GeneThera, said: "We are very happy to have signed this exclusive agreement with Nutricion Avanzada of Monterrey, Mexico. This alliance will give us the base of operations needed in Mexico to begin our commercialization process of our live animal test. The people at Nutricion Avanzada are very knowledgeable in the cattle industry and will be a great liaison between our company and the Mexican cattle industry."
Dr. Milici added: "This partnership, along with that of the one recently announced with Beckman Coulter (NYSE:BEC), coupled with our first revenue producing contracts with Xpention Genetics (OTCBB:XPNG), shows the commitment we have to bring our live animal test to market. We couldn't ask for three better partners to help us in this journey."
Sergio I. Gonzalez Gonzalez, principal of Nutricion Avanzada of Monterrey, Mexico, said: "We couldn't be more thrilled with the signing of this alliance agreement with GeneThera. We look forward to being GeneThera's partner throughout Mexico and to being a great asset for them in our country."
About GeneThera, Inc.
GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, Colo. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA(TM), a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA is designed for a host of individual diseases, the current priority being Mad Cow disease, Chronic Wasting Disease, a disease affecting elk and deer in North America, E.Coli 0157:H7 and Johnne's Disease, diseases affecting cattle worldwide.
"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.
